Impax Asset Management Group’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.78M Hold
175,000
0.03% 196
2025
Q1
$7.03M Hold
175,000
0.04% 171
2024
Q4
$8.23M Buy
175,000
+50,000
+40% +$2.35M 0.04% 177
2024
Q3
$6.6M Hold
125,000
0.03% 203
2024
Q2
$6.77M Buy
+125,000
New +$6.77M 0.03% 199